Published in Vaccine on May 23, 2009
Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med (2013) 2.52
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine (2012) 1.71
Clinical evaluation of a loop-mediated isothermal amplification (LAMP) assay for rapid detection of Neisseria meningitidis in cerebrospinal fluid. PLoS One (2015) 1.58
Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06. BMC Genomics (2010) 1.27
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Eur J Clin Microbiol Infect Dis (2012) 1.24
Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol (2012) 1.20
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis (2011) 1.19
Meningococcal disease and the complement system. Virulence (2013) 1.19
Microbial antigenic variation mediated by homologous DNA recombination. FEMS Microbiol Rev (2012) 1.18
Genealogical typing of Neisseria meningitidis. Microbiology (2009) 1.16
Bacterial outer membrane vesicles and vaccine applications. Front Immunol (2014) 1.16
A bacterial siren song: intimate interactions between Neisseria and neutrophils. Nat Rev Microbiol (2012) 1.14
An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol (2010) 1.07
The role of glyceraldehyde 3-phosphate dehydrogenase (GapA-1) in Neisseria meningitidis adherence to human cells. BMC Microbiol (2010) 0.99
Designing vaccines for the twenty-first century society. Front Immunol (2014) 0.92
Polar invasion and translocation of Neisseria meningitidis and Streptococcus suis in a novel human model of the blood-cerebrospinal fluid barrier. PLoS One (2012) 0.92
Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis. EBioMedicine (2015) 0.90
Prevalence and phase variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitidis. PLoS One (2013) 0.84
Review of meningococcal vaccines with updates on immunization in adults. Hum Vaccin Immunother (2014) 0.83
Type I Interferon Induction by Neisseria gonorrhoeae: Dual Requirement of Cyclic GMP-AMP Synthase and Toll-like Receptor 4. Cell Rep (2016) 0.83
Transmigration of polymorphnuclear neutrophils and monocytes through the human blood-cerebrospinal fluid barrier after bacterial infection in vitro. J Neuroinflammation (2013) 0.82
Family and community concerns about post-mortem needle biopsies in a Muslim society. BMC Med Ethics (2011) 0.82
Pro-inflammatory cytokines can act as intracellular modulators of commensal bacterial virulence. Open Biol (2013) 0.81
Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease. Hum Vaccin Immunother (2012) 0.81
Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant. PLoS One (2015) 0.80
Genomic Investigation Reveals Highly Conserved, Mosaic, Recombination Events Associated with Capsular Switching among Invasive Neisseria meningitidis Serogroup W Sequence Type (ST)-11 Strains. Genome Biol Evol (2016) 0.79
Meningococcal disease serogroup C. Risk Manag Healthc Policy (2012) 0.79
Spectroscopic evidence for a 5-coordinate oxygenic ligated high spin ferric heme moiety in the Neisseria meningitidis hemoglobin binding receptor. Biochim Biophys Acta (2014) 0.79
Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production. J Biol Chem (2014) 0.79
Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria. Int Health (2014) 0.79
Host cell-derived lactate functions as an effector molecule in Neisseria meningitidis microcolony dispersal. PLoS Pathog (2017) 0.79
The Capsule Polymerase CslB of Neisseria meningitidis Serogroup L Catalyzes the Synthesis of a Complex Trimeric Repeating Unit Comprising Glycosidic and Phosphodiester Linkages. J Biol Chem (2015) 0.78
Cloning, expression and purification of the factor H binding protein and its interaction with factor H. Iran J Microbiol (2016) 0.77
Role of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble Neisseria meningitidis adhesin A (rNadA) in human epithelial cells. PLoS One (2014) 0.77
[Meningococcus B: control of two outbreaks by vaccination]. J Prev Med Hyg (2014) 0.77
Neisseria gonorrhoeae FA1090 carries genes encoding two classes of Vsr endonucleases. J Bacteriol (2010) 0.77
A Novel Loop-Mediated Isothermal Amplification Assay for Serogroup Identification of Neisseria meningitidis in Cerebrospinal Fluid. Front Microbiol (2016) 0.77
Identification and therapeutic potential of a vitronectin binding region of meningococcal msf. PLoS One (2015) 0.76
Neisseria meningitidis Polynucleotide Phosphorylase Affects Aggregation, Adhesion, and Virulence. Infect Immun (2016) 0.76
Nuclear trafficking, histone cleavage and induction of apoptosis by the meningococcal App and MspA autotransporters. Cell Microbiol (2015) 0.76
Neisseria meningitidis elicits a pro-inflammatory response involving IκBζ in a human blood-cerebrospinal fluid barrier model. J Neuroinflammation (2014) 0.76
Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells. PLoS One (2016) 0.75
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012. J Prev Med Hyg (2014) 0.75
Genomic Analysis of Serogroup Y Neisseria meningitidis Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms. J Infect Dis (2016) 0.75
Fructose-1,6-bisphosphate aldolase of Neisseria meningitidis binds human plasminogen via its C-terminal lysine residue. Microbiologyopen (2016) 0.75
Disease-associated Neisseria meningitidis isolates inhibit wound repair in respiratory epithelial cells in a type IV pilus-independent manner. Infect Immun (2014) 0.75
Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage. J Prev Med Hyg (2015) 0.75
Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A (1998) 39.20
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature (2000) 9.86
Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med (1969) 9.01
Meningococcal disease. N Engl J Med (2001) 8.50
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell (2007) 6.84
Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet (1999) 6.02
Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A (1997) 5.90
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet (2007) 5.11
Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science (2007) 4.01
Serological relationships among meningococci. Bacteriol Rev (1953) 3.56
Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acad Sci U S A (1989) 2.83
CEACAM1: contact-dependent control of immunity. Nat Rev Immunol (2006) 2.81
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA (1990) 2.79
Interactions of pathogenic neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol (2000) 2.74
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis (2007) 2.70
Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med (2003) 2.39
MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine (2005) 2.20
Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol (1995) 2.18
Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis (2003) 2.16
Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A (2008) 2.06
Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun (2005) 2.05
Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol (2005) 1.99
Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis (2002) 1.92
MD-2 binds to bacterial lipopolysaccharide. J Biol Chem (2001) 1.91
Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol (2004) 1.89
Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: attachment and entry into columnar epithelial cells. J Infect Dis (1983) 1.86
Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit Rev Microbiol (1998) 1.82
The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun (1998) 1.78
Structural biology of the LPS recognition. Int J Med Microbiol (2007) 1.73
Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis (2003) 1.59
Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect Immun (2004) 1.59
Iron transport systems in Neisseria meningitidis. Microbiol Mol Biol Rev (2004) 1.58
Properdin deficiency in a family with fulminant meningococcal infections. Clin Exp Immunol (1982) 1.57
The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology (1999) 1.53
Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J Bacteriol (1996) 1.50
Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine (2007) 1.49
Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J Med Microbiol (1994) 1.44
Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med (1995) 1.37
Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis (1999) 1.30
Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis. J Cell Biol (2001) 1.29
Translocation and surface expression of lipidated serogroup B capsular Polysaccharide in Neisseria meningitidis. Infect Immun (2005) 1.19
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine (2005) 1.17
Paclitaxel binding to human and murine MD-2. J Biol Chem (2008) 1.13
Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures. J Cell Biol (2006) 1.10
Invasion of endothelial cells by Neisseria meningitidis requires cortactin recruitment by a phosphoinositide-3-kinase/Rac1 signalling pathway triggered by the lipo-oligosaccharide. J Cell Sci (2005) 1.05
Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells. Infect Immun (2008) 0.99
The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol (2000) 0.97
Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4. Glycobiology (2007) 0.94
Meningococcal conjugate vaccines. Expert Opin Pharmacother (2004) 0.92
Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children. Clin Infect Dis (2005) 0.91